Month: May 2022

In this article 2330-TW ADBE TWTR NVDA AMD Retail investors have continued to buy the dip in the recent market turmoil, even liking tech despite the sector rout, according to brokerage TD Ameritrade’s AJ Kahling. “Our indicators, TD Ameritrade [Investor Movement Index], just came out this morning indicating indeed that the retail traders are continuing
0 Comments
These 3 undervalued housing stocks can deliver attractive returns as the housing market remains strong and is resilient to economic conditions Williams-Sonoma (WSM): Strong sales growth and positive free cash flow trend are bullish Lennar (LEN): The stock price correction offers an investment opportunity hard to pass Toll Brothers (TOL): Strong Q1 earnings report beating
0 Comments
Winning new business can be hard enough for financial advisors. The landscape is tough and prospective clients have a lot of options in terms of seeking financial advice. The rise of online financial advisors (a.k.a roboadvisors) adds even another dimension to this equation. Keeping new clients happy and engaged is a challenge for financial advisors
0 Comments
TOKYO—Japanese technology investor SoftBank Group Corp. on Thursday reported the biggest annual loss in its four-decade history because of the global selloff in technology shares. SoftBank 9984, -8.03%, known for its $100 billion Vision Fund, reported a net loss of ¥1.71 trillion, equivalent to $13.2 billion, for the year that ended March 31. That was
0 Comments
In this article GBTC Michael Sonnenshein, CEO, Grayscale Investments at the NYSE, April 18, 2022. Source: NYSE Grayscale, the asset manager running the world’s largest bitcoin fund, met privately with the Securities and Exchange Commission last week in an effort to persuade the regulator to approve the conversion of its flagship fund into an ETF,
0 Comments
What Determines Bitcoin’s Price? Bitcoin (BTCUSD) is a cryptocurrency developed in 2009 by Satoshi Nakamoto, the name given to the unknown creator (or creators) of this virtual currency. Transactions are recorded in a blockchain, which shows the transaction history for each unit and proves ownership. Unlike investing in traditional currencies, Bitcoin is not issued by
0 Comments
Biotech stocks have been through an extended lean patch, making them ideal candidates for a strong rebound. Verrica (VRCA): Approval of its viral skin disease treatment could transform the company into a commercial-stage biopharma. Amicus (FOLD): Pompe disease treatment approval opens up huge market opportunity for the biopharma. Athersys (ATHX): Potential approval for Japanese licensee
0 Comments
If you’re the type that throws caution to the wind, these deflated but intriguing growth stocks to buy may liven up your portfolio in the long run. Bloom Energy (BE): Although the fuel-cell specialist suffered a poor earnings report, the underlying message has become even more critical. Rivian Automotive (RIVN): Highly risky due to supply
0 Comments